Search Results
Jun 30, 2026, 08:00 ET Virtual Vision Health Surpasses 2.5 Million Exams and 1 Million Patients Worldwide
supporting eye care providers worldwide with solutions that improve outcomes for patients and practices alike.About Virtual Vision HealthVirtual Vision Health aims to provide eye care professionals with a better way to diagnose and manage ocular conditions. The suite of Virtual Eye products
More news about: Virtual Vision Health
Jun 30, 2026, 08:00 ET Big Tech is Struggling To Power the Multi-Trillion-Dollar AI Boom
controls more capacity than most pure-play providers while already generating revenue from Bitcoin mining.Other companies to keep an eye on:Broadcom Inc. (NASDAQ: AVGO) makes the custom AI accelerators
More news about: OilPrice.com
Jun 30, 2026, 05:24 ET Kikkoman India Hosts 4th Culinary Experts Meetup in New Delhi -- Food Service Professionals Gather to Discuss 'Trust' and 'Authenticity'
InternationalModerated by: Ms. Sumana Mukherjee — Veteran Journalist and EditorPanel Discussion 2: 'Fake or Real? Cultivating an Eye for Authenticity'This panel reframed authenticity not as a fixed, static concept but as something inherently dynamic — shaped by local ingredients,
More news about: Kikkoman India
Jun 30, 2026, 03:11 ET Roca Introduces Touch-T: A New Benchmark in Thermostatic Shower Systems
user steps in, every element from the ergonomic Mega Button to the dual-control knobs has been designed to feel natural in the hand and clear to the eye.The Mega Button is the system's defining gesture. Ergonomically shaped to fit the fingertip precisely, it activates powerful water flow
More news about: Roca India
Jun 30, 2026, 00:00 ET Innovent Biologics and Lilly Enter into Commercialization Agreement for Verzenios® (abemaciclib) in Mainland China
innovative medicines that target some of the most intractable diseases. Its pioneering therapies treat cancer, cardiovascular and metabolic, autoimmune and eye diseases. Innovent has launched 19 products in the market. It has 1 asset in NMPA NDA review, 5 assets in Phase 3 or pivotal clinical trials and 14 more
More news about: Innovent Biologics
Jun 29, 2026, 22:32 ET XAILIENT ANNOUNCES SUCCESSFUL INDEPENDENT VALIDATION OF CASINO EYE-D BY GAMING LABORATORIES INTERNATIONAL (GLI)
that Gaming Laboratories International (GLI) has conducted a successful independent validation of the company's ground breaking Casino Eye-D FR platform.
More news about: Xailient
Jun 29, 2026, 19:30 ET ASUS Education and Intel Showcase AI-Ready Technology for K-12 Schools at ISTE+ASCD 2026
professional-grade OLED panels for creative programs, and portable screens for flexible learning. The ASUS BE249CGN is designed for long hours at the desk without eye fatigue. The ProArt Display OLED PA27USD delivers professional 4K color accuracy. The ASUS ZenScreen MB169CK-P connects with a single USB-C and gives
More news about: ASUS Computer International
Jun 29, 2026, 12:18 ET MUFG leads Viva Aerobus's debut JOLCO
philosophy is embodied in the three "i"s of "intelligence," "investment," and "I" in the first person, with the highest integrity to be the perceptive "third eye" for our clients. The core focus is on shipping and aviation leasing and Japanese real estate, while also engaging in principal investments in the real
More news about: MUFG Bank, Ltd.
Jun 29, 2026, 11:00 ET USPS Announces Additional Stamps and Release Locations for 2026
red-white-and-blue digital image of a detail of the U.S. flag. Bryan Duefrene, an art director for USPS, designed the stamp image. "I was looking for a bolder, eye-catching way of portraying the flag and decided to focus on the elements of the Stars and Stripes rather than the flag as a whole," Duefrene said. "I
More news about: U.S. Postal Service
Jun 29, 2026, 10:01 ET Therapeutic Contact Lenses Market to Reach USD 35.2 Billion by 2036 Driven by Advanced Corneal Care, Drug Delivery Innovation, and Expanding Ophthalmic Procedures
clinics.Key Growth DriversRising cases of chronic eye disorders, including dry eye disease, corneal injuries, keratitis, and diabetic eye complications, are driving demand for therapeutic contact lenses due to the need for long-term eye care and repeat prescriptions. Post-surgical applications
More news about: Future Market Insights
Jun 29, 2026, 10:00 ET Zenni Optical Reintroduces Zunnies Collection with Expanded Sunglass Styles and New Zunscreen™ Lens Technology
system that filters not only UV, but also blue light, infrared wavelengths, and glare, delivering a more complete, science-backed approach to everyday eye protection."With over 2,000 styles, Rx options, and accessible price points, Zunnies delivers on both fashion and function without compromise.
More news about: Zenni Optical
Jun 29, 2026, 09:04 ET MiniMed appoints Alcon CEO David Endicott and Linnea Burman to its Board of Directors
executive with leadership experience across global pharmaceutical and medical device companies. He currently serves as Chief Executive Officer of Alcon, an eye care company, and has served as a member of Alcon's board of directors since 2019. He joined Alcon in July 2016 as Chief Operating Officer, was named
More news about: MiniMed
Jun 29, 2026, 09:00 ET PARTICLE ANNOUNCES GOLF LEGEND ROCCO MEDIATE AS NEW AMBASSADOR
formulas feature clinically backed ingredients like peptides, retinol, hyaluronic acid, and antioxidants to help target visible signs of aging, including eye bags, dark spots, and wrinkles. Through cutting-edge research and molecular biology, Particle is redefining men's personal care with products designed
More news about: Particle
Jun 29, 2026, 09:00 ET SwitchBot Expands Matter-Enabled Lighting Portfolio with RGBICWW Ceiling Light
with CRI ≥90, helping restore more natural colors in food, artwork, furniture, and home decor. Flicker-free and glare-reduced lighting helps reduce eye fatigue during reading, studying, working, and long-term use, while gradual on/off transitions create smoother brightness changes that feel more natural
More news about: SwitchBot
Jun 29, 2026, 09:00 ET SwitchBot Expands Matter-Enabled Lighting Portfolio with RGBICWW Ceiling Light
with CRI ≥90, helping restore more natural colors in food, artwork, furniture, and home decor. Flicker-free and glare-reduced lighting helps reduce eye fatigue during reading, studying, working, and long-term use, while gradual on/off transitions create smoother brightness changes that feel more natural
More news about: SwitchBot
Jun 29, 2026, 09:00 ET MemoMind Begins Accepting Orders of Its First AI Glasses
MemoMind One blends ultralight comfort with adaptive intelligence, delivering AI assistance that works quietly in the background. The glasses combine dual-eye display technology with integrated audio and a multi-LLM hybrid operating system to support real-time translation, intelligent note-taking, contextual
More news about: XGIMI
Jun 29, 2026, 08:00 ET Power Shortages Threaten to Derail the Trillion Dollar AI Boom
the same infrastructure can generate cash flow today and scale into larger contracts as AI demand continues to build.Other companies to keep an eye on:Microsoft Corporation (NASDAQ: MSFT) is in the middle of the largest infrastructure build-out in its history. The company pledged roughly
More news about: OilPrice.com
Jun 29, 2026, 07:40 ET XPENG Unveils X-Mind: Empowering Autonomous Driving with a "Future-Foresight" Brain
internal simulation. Its three core technologies include:Thought Sketch, which creates an efficient cognitive representation combining Bird's-Eye-View (BEV) layouts and driving priors, preserving key elements such as road structures, obstacles, traffic lights, and navigation intentions while reducing
More news about: XPeng Inc.
Jun 29, 2026, 07:30 ET Biohaven Advances a New Class of Precision Immunology Therapies: First MoDE Extracellular Protein Degrader, BHV-1300, Begins Phase 3 Pivotal Trial in Graves' Disease
the gland. BHV-1300 represents an opportunity to bring forward a disease modifying therapy, targeting the underlying cause of Graves' disease, thyroid eye disease, and pretibial myxedema rather than addressing the downstream complications."BHV-1300 is the lead molecule from Biohaven's MoDE platform
More news about: Biohaven Ltd.
Jun 29, 2026, 07:05 ET REGENXBIO Announces First Patient Dosed in Phase IIb/III NAAVIGATE Trial of Surabgene Lomparvovec in Diabetic Retinopathy; Company to Receive $100 Million Milestone
performed by REGENXBIO for an ongoing trial.1 Penn JS, Madan A, Caldwell RB, et al. Vascular endothelial growth factor in eye disease. Prog Retin Eye Res. 2008;27(4):331-71.2 Cheung N, Mitchell P, Wong TY. Diabetic retinopathy. Lancet. 2010;376(9735):124–36.3 Lundeen
More news about: REGENXBIO Inc.
Jun 29, 2026, 06:00 ET Where to Buy Contact Lenses (2026): EZContacts Named Top Trusted Source by Expert Consumers
informed decision-making.Brand-specific shoppers are also accommodated. Eye care professionals often prescribe a specific contact lens brand and model based on a patient's vision correction needs, fit, comfort, and eye health. EZContacts offers access to widely recognized and commonly prescribed
More news about: ExpertConsumers.org
Jun 29, 2026, 03:00 ET xTool Launches O1 Omni Printer: The World's First All-in-One Desktop Printer for Virtually Any Material
avoiding holes (e.g., camera cutouts). It also supports a 2000+ Texture Library for 7mm 3D relief and a Lenticular 3D Generator for eye-catching, naked-eye 3D effects.Eco-Friendly Safety & Automated Maintenance: Designed for worry-free production, the O1 uses GREENGUARD-certified,
More news about: xTool
Jun 27, 2026, 17:30 ET The SpaceX IPO Lifted the Whole Space Economy -- Including the Public Companies Building the Road Back to the Moon
helped illuminate, the names are now public and the milestones are now scheduled — with the data, as always, still to be delivered. To keep a closer eye on the launch, satellite, lunar, and space-data economy as it develops, sign
More news about: American News Group
Jun 27, 2026, 08:08 ET The SpaceX IPO Put a Spotlight on Starlink -- and on the One Public Company Building a Rival Direct-to-Phone Network
satellite-to-phone is real, but who builds the winning network. The answer will come from orbit, on a schedule, over the next several years. To keep a closer eye on the launch, satellite, lunar, and space-data economy as it develops, sign
More news about: Equity Insider
Jun 26, 2026, 12:35 ET Johnson & Johnson presents new IMAAVY® (nipocalimab-aahu) data at European Academy of Neurology (EAN) 2026 Congress reinforcing sustained disease control in generalized myasthenia gravis
with over 65% of pediatric MG cases in the U.S. diagnosed in girls.22,23,24Initial disease manifestations are usually eye-related, but approximately 85% of MG patients experience additional advancements to the disease manifestations, referred to as generalized myasthenia gravis
More news about: Johnson & Johnson